Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.18 | N/A |
PEG Ratio (TTM) | 0.00 | N/A |
P/S Ratio (TTM) | 1.30 | N/A |
P/B Ratio (TTM) | 1.78 | N/A |
P/FCF Ratio (TTM) | -1.12 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -51.45% | N/A |
ROE (TTM) | -103.85% | N/A |
Net Profit Margin (TTM) | -110.29% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -35.45% | -110,076.77% | N/A |
Revenue | 0.44% | 39.15% | N/A |
Net Income | -35.75% | -82,495.34% | N/A |
Cash Flow | -433.24% | -95,637.24% | N/A |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.96 | N/A |
Quick Ratio (TTM) | 1.60 | N/A |
D/E Ratio (TTM) | 1.14 | N/A |
Interest Coverage (TTM) | -3.63 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |